Mitochondrial Diseases

Known causes include inherited or acquired mutations in mitochondrial DNA and nuclear genes that code for mitochondrial components. The grounding also supports acquired mitochondrial dysfunction from adverse effects of drugs, infections, and other environmental causes.

The core biological problem is impaired mitochondrial function, especially reduced ability to generate ATP appropriately in response to energy demand. The literature grounding also links disease biology to altered electron transport, energy metabolism, autophagy, and mitophagy, reflecting defective maintenance and turnover of mitochondria.

Genetic susceptibility from mutations in mitochondrial DNA or nuclear genes increases risk. Acquired exposures such as drugs, infections, and other environmental causes can also increase risk by inducing mitochondrial dysfunction.

The supplied grounding supports therapy as a general aspect of management but does not provide disease-specific standard treatments. It indicates that mitochondrial dysfunction is a therapeutic target and mentions emerging strategies such as mitochondrial replacement or replenishment approaches, but not a standard modality for all mitochondrial diseases.